State of Wyoming Sells 17,614 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• The State of Wyoming reduced its stake in Alignment Healthcare, Inc. by 66.9%, selling 17,614 shares, resulting in ownership of 8,723 shares valued at $162,000.
• Alignment Healthcare reported $1.02 billion in revenue for the most recent quarter, exceeding the consensus estimate of $960.25 million, despite posting a negative EPS of $0.07.
• Analysts have mixed ratings on Alignment Healthcare, with one upgrade to "strong-buy" and a consensus price target of $18.83, reflecting a "Moderate Buy" outlook.

State of Wyoming cut its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 66.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,723 shares of the company's stock after selling 17,614 shares during the period. State of Wyoming's holdings in Alignment Healthcare were worth $162,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. MCF Advisors LLC raised its position in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare during the first quarter worth approximately $42,000. Amalgamated Bank raised its position in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after purchasing an additional 616 shares during the period. Tower Research Capital LLC TRC raised its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after purchasing an additional 6,286 shares during the period. Finally, Voloridge Investment Management LLC acquired a new position in shares of Alignment Healthcare during the fourth quarter worth approximately $189,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Trading Down 2.7%

Shares of Alignment Healthcare stock opened at $15.86 on Friday. The company has a market capitalization of $3.14 billion, a P/E ratio of -56.64 and a beta of 1.17. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a fifty day simple moving average of $14.18 and a 200 day simple moving average of $15.42. Alignment Healthcare, Inc. has a 12-month low of $8.65 and a 12-month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's revenue for the quarter was up 49.0% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ALHC. Zacks Research raised Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a report on Monday, August 25th. Finally, Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 60,000 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $14.60, for a total value of $876,000.00. Following the completion of the transaction, the insider owned 642,953 shares in the company, valued at $9,387,113.80. This represents a 8.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Hyong Kim sold 24,800 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.00, for a total value of $396,800.00. Following the completion of the transaction, the insider owned 447,367 shares of the company's stock, valued at $7,157,872. This trade represents a 5.25% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 636,185 shares of company stock worth $9,235,468. Company insiders own 7.00% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.